⌘K

Login Start Free

Home/Filings/4/0001209191-15-027299

4//SEC Filing

EAGLE PHARMACEUTICALS, INC. 4

Accession 0001209191-15-027299

CIK 0000827871operating

View on SEC.gov Company Profile

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 8:07 PM ET

Size

5.3 KB

Accession

0001209191-15-027299

Insider Transaction Report

Form 4

Period: 2015-03-13

EAGLE PHARMACEUTICALS, INC.EGRX

Director

Transactions

Award
Option (right to buy)
2015-03-13+5,000→ 5,000 total
Exercise: $46.09Exp: 2025-03-12→ Common Stock (5,000 underlying)

Footnotes (1)

[F1]The option fully vests on March 13, 2016, subject to the reporting person's continuous service with the issuer as of the vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

EAGLE PHARMACEUTICALS, INC.

CIK 0000827871

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000827871

Filing Metadata

Form type: 4
Filed: Mar 16, 8:00 PM ET
Accepted: Mar 17, 8:07 PM ET
Size: 5.3 KB

View on SEC.gov